News coverage about Nanosphere (NASDAQ:NSPH) has trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Nanosphere earned a coverage optimism score of 0.14 on Accern’s scale. Accern also gave media coverage about the medical research company an impact score of 44.8174916175945 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the near term.

TRADEMARK VIOLATION WARNING: This report was first posted by Daily Political and is the property of of Daily Political. If you are reading this report on another publication, it was illegally copied and reposted in violation of international trademark and copyright law. The original version of this report can be read at https://www.dailypolitical.com/2017/08/10/nanosphere-nasdaqnsph-earning-somewhat-favorable-news-coverage-report-shows.html.

About Nanosphere

Nanosphere, Inc is engaged in developing, manufacturing and marketing an advanced molecular diagnostics platform, the Verigene System, which enables genomic and protein testing on a single platform. The Verigene System includes a molecular diagnostics workstation that is a single use consumable for testing.

Insider Buying and Selling by Quarter for Nanosphere (NASDAQ:NSPH)

Receive News & Ratings for Nanosphere Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nanosphere Inc. and related companies with MarketBeat.com's FREE daily email newsletter.